Vanderbilt University Medical Center is reviewing its clinical IT systems in an effort to replace key elements, including tools for clinical decision support, nursing documentation and medication management.
McKesson Corp., the vendor for the various applications, has announced it will no longer support those clinical products as of March 2018. Due to the technology's scope, only two contenders are available to replace McKesson's products: Cerner Corp. and Epic Systems Corp. VUMC has tapped Deloitte Consulting to assist with vendor selection.
One of the applications, Horizon Expert Orders, was developed based on technology developed at VUMC and called WizOrder, which was licensed to McKesson in 2001. The application was later back-installed at VUMC.
"We want to understand where we are today with our functionality, and also what our clinicians say we don't have and what we could really use," Mark Ciampa, director of VUMC's HealthIT program management office, said in a statement. "We'll be interviewing physicians, nurses and other staff in the hospital and clinics to help us evaluate current functionality and things that we have today that we really need."
For more, click here.
Capella Healthcare announced Thursday seven promotions, including Angie Mulder to vice president, corporate compliance officer and Andretta Reed to vice president, HIM operations and coding. Mulder is a former senior director of ethics and compliance at LifePoint Hospitals, while Reed joined Franklin-based Capella in 2012 as director of coding and revenue integrity.
The company also announced the following promotions:
•Brent Jean, assistant vice president of reimbursement
•Scott Fleischer, director of financial IT applications
•Barb Hojer, director of human resources
•Kevin Townes, director of technical services
•Amanda Herbert, senior analyst of patient portals
"We are pleased to announce promotions for these high-performing members of our corporate resource team," Michael Wiechart, Capella CEO, said in a release. "Capella has a talented and experienced team of colleagues that are dedicated to serving our hospitals. Health care is complex industry and it is vital that hospitals have access to strong leadership resources. Or corporate resource team is a vital part of our hospitals' success."
HCA Holdings on Friday paid $294 million to buy back a big block of its shares from Bain Capital, one of the firms that took the hospital giant private back in 2006 and then public again less than five years later. The purchase is the third such deal in a year — HCA paid $750 million in May and $558 million in December to cut Bain's stake to less than 3 percent — and helps completely cash out the firm.
The Securities and Exchange Commission filing from HCA also details that the company has been very active on the buyback front since announcing a $1 billion plan in early February: The Bain purchase brings to no less than $745 million the company's outlays over the past 11 weeks. Over that time, HCA shares (Ticker: HCA) are up 12 percent.
HCA Holdings COO Sam Hazen has taken advantage of the record run in the hospital giant's shares — they're up 60 percent in the past year (Ticker: HCA) — via his option holdings for the second time in four months. Last Wednesday, a stock trading plan set up by Hazen last summer exercised 180,000 options for $5.31 each and then sold the same number of shares at $80 apiece. His gain on those transactions topped $13.4 million. Hazen's plan — which late last year also generated almost $11 million in profits — also paid a little more than $2 million to exercise another 180,000 options before forfaiting about half of those to cover its expenses. The moves leave Hazen, who was named to his current position in January, with almost $10 million in direct holdings.
RBC Capital analyst Frank Morgan has reiterated his 'buy' rating for HCA Holdings.
Morgan also raised his price target for the Nashville company to $88. Last fall, his price target for HCA Holdings, which Wednesday previewed better than expected Q1 earnings, was $83.
Shares of HCA (Ticker: HCA) were down nearly 2 percent Thursday afternoon to $77.78. Year to date, they're up almost 6 percent.
POSTDATA: WARRANTY DEEDS